Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
June 27, 2024 16:08 ET
|
Gain Therapeutics, Inc.
Mr. Mack is the Company’s Current CFO Khalid Islam, PhD, Founder and Chairman of the Board, to serve as Executive Chairman BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics,...
Kura Sushi USA Announces Preliminary Unaudited Fiscal Third Quarter 2024 Financial Results
June 27, 2024 16:05 ET
|
Kura Sushi USA
IRVINE, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced preliminary...
Abcourt Closes a Final Tranche of the Private Placement of Units Previously Announced, for an Additional Amount of $627,570
June 27, 2024 16:05 ET
|
Abcourt Mines Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ROUYN-NORANDA, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the...
Elicio Therapeutics Announces Proposed Public Offering
June 27, 2024 16:05 ET
|
Elicio Therapeutics Inc.
BOSTON, June 27, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel...
Workhorse Expands Product Offering with Upfit Solutions from Surefitters
June 27, 2024 16:05 ET
|
Workhorse Group, Inc.
CINCINNATI, June 27, 2024 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission...
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
June 27, 2024 16:05 ET
|
Acasti Pharma, Inc.
PRINCETON, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...
Avadel Pharmaceuticals to Join Russell 3000® Index
June 27, 2024 16:05 ET
|
Avadel Pharmaceuticals plc
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set...
Verizon elects Caroline A. Litchfield to its Board of Directors
June 27, 2024 16:05 ET
|
Verizon Communications, Inc.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) today announced the election of Caroline A. Litchfield, Executive Vice President and Chief Financial...
Horizon Bancorp, Inc. Announces Conference Call to Review Second Quarter Results on July 25
June 27, 2024 16:05 ET
|
Horizon Bancorp, Inc.
Horizon Bancorp, Inc. ("Horizon" or the "Company") will host a conference call at 7:30 a.m. CT on Thursday, July 25, 2024 to review its second quarter 2024
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
June 27, 2024 16:05 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2024 financial and operating results on...